Glenmark brings relief with FabiFlu, priced @ Rs 103 a tablet

Glenmark brings relief with FabiFlu, priced @ Rs 103 a tablet: Glenmark developed active pharmaceutical ingredient and formulation for FabiFlu through in-house R&D; DCGI allowed fast track trials with Phase III in limited patients; approval process is also under Emergency Use Authorisation. The drug acts by getting into cells and inhibit the activity of viral replication to reduce the viral load.

Comments

Popular posts from this blog

Panasonic India to Launch Eluga Series of Smartphones

Intex launches Aquq Octa Smartphone